
Shares of drugmaker Merck MRK.N rise 1.5% to $124.10 premarket
Co says it will split its human health operations into an Oncology unit and a Specialty, Pharma & Infectious Diseases unit to improve performance ahead of multiple product launches
Co says Jannie Oosthuizen will lead oncology; Brian Foard joins from Sanofi SASY.PA to head the second unit starting March 2
Says restructuring supports its late‑stage pipeline, which includes about 80 late‑stage studies and more than 20 potential new products
Co also names Chirfi Guindo as executive vice president for Strategic Access, Policy & Communication
Merck shares rose ~6% in 2025